Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP523819.RA8yKEKXFJrNEUKiRH8OA5GYY7TgBAVwYXI3-uGKHt3Ls130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP523819.RA8yKEKXFJrNEUKiRH8OA5GYY7TgBAVwYXI3-uGKHt3Ls130_assertion type Assertion NP523819.RA8yKEKXFJrNEUKiRH8OA5GYY7TgBAVwYXI3-uGKHt3Ls130_head.
- NP523819.RA8yKEKXFJrNEUKiRH8OA5GYY7TgBAVwYXI3-uGKHt3Ls130_assertion description "[Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523819.RA8yKEKXFJrNEUKiRH8OA5GYY7TgBAVwYXI3-uGKHt3Ls130_provenance.
- NP523819.RA8yKEKXFJrNEUKiRH8OA5GYY7TgBAVwYXI3-uGKHt3Ls130_assertion evidence source_evidence_literature NP523819.RA8yKEKXFJrNEUKiRH8OA5GYY7TgBAVwYXI3-uGKHt3Ls130_provenance.
- NP523819.RA8yKEKXFJrNEUKiRH8OA5GYY7TgBAVwYXI3-uGKHt3Ls130_assertion SIO_000772 24755544 NP523819.RA8yKEKXFJrNEUKiRH8OA5GYY7TgBAVwYXI3-uGKHt3Ls130_provenance.
- NP523819.RA8yKEKXFJrNEUKiRH8OA5GYY7TgBAVwYXI3-uGKHt3Ls130_assertion wasDerivedFrom befree-20150227 NP523819.RA8yKEKXFJrNEUKiRH8OA5GYY7TgBAVwYXI3-uGKHt3Ls130_provenance.
- NP523819.RA8yKEKXFJrNEUKiRH8OA5GYY7TgBAVwYXI3-uGKHt3Ls130_assertion wasGeneratedBy ECO_0000203 NP523819.RA8yKEKXFJrNEUKiRH8OA5GYY7TgBAVwYXI3-uGKHt3Ls130_provenance.